Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5UBT

CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4] TRIAZIN-4-AMINE DERIVIATINE

Summary for 5UBT
Entry DOI10.2210/pdb5ubt/pdb
Related5ubr
DescriptorPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, 1-[4-(3-{4-amino-5-[1-(oxan-4-yl)-1H-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)piperazin-1-yl]ethan-1-one, ... (4 entities in total)
Functional Keywordslipid kinase, inhibitor, pi3k delta, transferase-transferase inhibitor complex, transferase-transferase regulator complex, transferase/transferase regulator
Biological sourceHomo sapiens (Human)
More
Cellular locationCytoplasm : O00329
Total number of polymer chains2
Total formula weight137161.81
Authors
Sack, J.S. (deposition date: 2016-12-21, release date: 2017-02-08, Last modification date: 2024-03-06)
Primary citationQin, L.Y.,Ruan, Z.,Cherney, R.J.,Dhar, T.G.,Neels, J.,Weigelt, C.A.,Sack, J.S.,Srivastava, A.S.,Cornelius, L.A.,Tino, J.A.,Stefanski, K.,Gu, X.,Xie, J.,Susulic, V.,Yang, X.,Yarde-Chinn, M.,Skala, S.,Bosnius, R.,Goldstein, C.,Davies, P.,Ruepp, S.,Salter-Cid, L.,Bhide, R.S.,Poss, M.A.
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3K delta inhibitors.
Bioorg. Med. Chem. Lett., 27:855-861, 2017
Cited by
PubMed Abstract: As demonstrated in preclinical animal models, the disruption of PI3Kδ expression or its activity leads to a decrease in inflammatory and immune responses. Therefore, inhibition of PI3Kδ may provide an alternative treatment for autoimmune diseases, such as RA, SLE, and respiratory ailments. Herein, we disclose the identification of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent, selective and orally bioavailable PI3Kδ inhibitors. The lead compound demonstrated efficacy in an in vivo mouse KLH model.
PubMed: 28108251
DOI: 10.1016/j.bmcl.2017.01.016
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.83 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon